Human immunodeficiency virus type 1 structural protein (HIV-1 structural protein)

Human immunodeficiency virus type 1 (HIV-1) "structural proteins" is a collective, over-broad term that includes multiple distinct gene products encoded by the HIV-1 genome, most notably the Gag, Pol, and Env polyproteins.[2][7] These polyproteins are processed into mature proteins which are essential for virus structure and function: - **Gag** is processed into matrix (p17), capsid (p24), nucleocapsid (p7), and other smaller proteins, creating the viral shell and core.[2][7][9] - **Pol** encodes viral enzymes: reverse transcriptase, integrase, and protease, which are required for RNA-to-DNA conversion, genome integration, and protein processing, respectively.[2][7][1] - **Env** is processed to generate glycoproteins gp120 and gp41, forming the surface spikes of the virion necessary for host cell entry.[2][7] These proteins are well-established therapeutic targets for antiretroviral drugs (e.g., reverse transcriptase inhibitors, protease inhibitors, integrase inhibitors, fusion inhibitors), with the capsid recently targeted by lenacapavir.[3][9] However, the query "HIV-1 structural proteins" is not a precise target, as drug discovery and biological research focus on individual components (e.g., HIV-1 reverse transcriptase, HIV-1 protease, HIV-1 gp120, etc.), each of which has specific functions and pharmacology.[2][7][9] Thus, this term should be resolved into its constituent proteins for structured data. **Key information:** - The term "HIV-1 structural proteins" refers collectively to a group of distinct viral proteins, not a unique molecule or receptor. - Each component (Gag, Pol, Env-derived proteins) is the actual biological and therapeutic target and should be entered separately for precision.[2][7] - Drugs, mechanisms of action, and biomarkers correspond to these individual proteins.[2][9][3] In summary: The entry "Human immunodeficiency virus type 1 structural proteins" is overly broad and encompasses several pharmacologically relevant targets. For structured information, specify each protein (e.g., HIV-1 reverse transcriptase, HIV-1 protease, HIV-1 capsid protein) rather than this collective term.

Other names

HIV-1 Gag proteinHIV-1 Pol proteinHIV-1 Env proteinHIV-1 capsid proteinHIV-1 matrix proteinHIV-1 nucleocapsid proteinHIV-1 envelope glycoprotein

Inhibition of reverse transcriptase, Inhibition of protease, Inhibition of integrase, Inhibition of envelope-mediated fusion